Immunocore Holdings (IMCR) FCF Margin (2023 - 2026)

Immunocore Holdings has disclosed FCF Margin across 4 years of filings, most recently posting 14.58% for Q1 2026.

• FCF Margin for Q1 2026 came in at 14.58%, down 1473.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.45% (down 1525.0% YoY), and the FY2025 annual result was 3.76%, down 1050.0% from the prior year.
• FCF Margin came in at 14.58% for Q1 2026 at Immunocore Holdings, up from 34.01% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 30.69% in Q2 2024 to a low of 34.01% in Q4 2025.
• The 4-year median for FCF Margin is 2.26% (2023), against an average of 0.07%.
• Across the five-year window, FCF Margin jumped 3295 bps in 2024 and plunged 3031 bps in 2025, its largest moves.
• Immunocore Holdings' FCF Margin stood at 26.44% in 2023, then increased by 21 bps to 20.86% in 2024, then tumbled by 63 bps to 34.01% in 2025, then jumped by 57 bps to 14.58% in 2026.
• The last three FCF Margin figures came in at 14.58% (Q1 2026), 34.01% (Q4 2025), and 5.02% (Q3 2025), per Business Quant data.